Pneumologia

Diretriz de consenso internacional sobre apneia obstrutiva do sono.

12 Set, 2022 | 11:32h

International consensus statement on obstructive sleep apnea – Allergy & Rhinology (PDF)

 

---

Revisão sistemática | Fisioterapia torácica para pneumonia em adultos.

12 Set, 2022 | 11:26h

Chest physiotherapy for pneumonia in adults – Cochrane Library

Resumo: Chest physiotherapy for pneumonia in adults – Cochrane Library

 

---

Série Lancet | Síndrome da angústia respiratória aguda 2022.

8 Set, 2022 | 14:22h

Página principal: Acute Respiratory Distress Syndrome 2022 – The Lancet

Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes

Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management

Opportunities for improved clinical trial designs in acute respiratory distress syndrome

Addressing the inequity of acute respiratory distress syndrome

 

---

Revisão | Oximetria de pulso para diagnóstico e tratamento da síndrome da angústia respiratória aguda.

8 Set, 2022 | 14:06h

Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome – The Lancet Respiratory Medicine

 

---

Revisão sistemática | Probióticos na prevenção de infecções agudas do trato respiratório superior.

8 Set, 2022 | 14:05h

Probiotics for preventing acute upper respiratory tract infections – Cochrane Library

 

Comentário no Twitter

#probiotics for preventing colds? @CochraneARI looked at 24 studies w 6,950 people.
👍 may be beneficial in preventing at least 1 occurrence of acute upper respiratory tract infection #URTI & likely beneficial in preventing 3 occurrences of URTIs.https://t.co/A6XxrjKKcI pic.twitter.com/mDR3NYLLzQ

— The Cochrane Library (@CochraneLibrary) August 24, 2022

 

---

Estudo sugere que a inteligência artificial (IA) melhora a interpretação da radiografia torácica.

8 Set, 2022 | 14:02h

Comentário: Study Suggests AI Improves Chest X-Ray Interpretation – Diagnostic Imaging

Estudo original: Association of Artificial Intelligence–Aided Chest Radiograph Interpretation With Reader Performance and Efficiency – JAMA Network Open

 

Comentário no Twitter

AI-aided interpretation improves reader performance and efficiency for identifying major thoracic findings on chest radiographs. @MGH_Webster #OpenAccess #Research https://t.co/JdgW55BgL7

— JAMA Network Open (@JAMANetworkOpen) August 31, 2022

 

---

Estudo randomizado | Segmentectomia anatômica vs. lobectomia padrão para câncer de pulmão de não pequenas células de até 2 cm.

8 Set, 2022 | 13:46h

Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm – Lung Cancer

Conteúdos relacionados:

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation.

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial – The Lancet (link para o resumo – $ para o texto completo)

A Meta-Analysis Comparing Lobectomy versus Segmentectomy in Stage I Non-Small Cell Lung Cancer – The Korean Journal of Thoracic and Cardiovascular Surgery

 

---

Estudo randomizado fase 2 | Segurança, tolerabilidade e eficácia da pirfenidona em pacientes com doença pulmonar intersticial associada a artrite reumatoide.

8 Set, 2022 | 13:41h

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study – The Lancet Respiratory Medicine

 

Comentário no Twitter

NEW Research—Pirfenidone slowed the rate of decline of FVC over time in patients with RA-ILD*

Being presented at #ERSCongress, ALERT 3 session, Sept 5 from 13:15 BST

From Joshua Solomon & colleagues https://t.co/Nu8wECECdD

*(please check study limitations) pic.twitter.com/IuRxLDZGd9

— The Lancet Respiratory Medicine (@LancetRespirMed) September 5, 2022

 

---

Estudo randomizado | Broncodilatadores não melhoram os sintomas respiratórios relacionados ao tabagismo em pessoas sem DPOC.

6 Set, 2022 | 13:15h

Comunicado de imprensa: Bronchodilators don’t improve smoking-related respiratory symptoms in people without COPD – NIH News Releases

Estudo original: Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function – New England Journal of Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

This trial involving symptomatic, tobacco-exposed persons with preserved lung function onspirometry showed no benefit to the use of dual bronchodilator therapy. https://t.co/kXqXHMl2xx pic.twitter.com/KAMuI4Jajo

— NEJM (@NEJM) September 4, 2022

 

---

FDA autoriza doses de reforço atualizadas para novas variantes do COVID com vacinas da Moderna e da Pfizer.

6 Set, 2022 | 13:11h

FDA authorizes updated COVID boosters from Moderna and Pfizer – CIDRAP

Comunicado de imprensa do FDA: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose – U.S. Food & Drug Administration

 

---